Novartis wins lawsuit against government

Published: 2011-03-07 06:59:00

Updated: 2011-03-07 06:59:00

A Seoul Court ruled that the Ministry of Health, Welfare and Family Affairs should withdraw the decision to lower the price of Glivec, Switzerland based Novartis’s leukemia drug by 14 percent in September 2009.

In December, the Seoul High Court upheld the appellate court’s verdict,” stating, “...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK